Cellectis (CLLS) Total Debt (2014 - 2026)
Cellectis' (CLLS) quarterly Total Debt came in at $76.4 million in Q1 2026, up 12.65% year-on-year from $67.8 million in Q1 2025, and down 9.55% quarter-over-quarter from $84.5 million in Q4 2025.
Cellectis (CLLS) Total Debt (2014 - 2026) Analysis & Trends
Cellectis' Total Debt history runs 13 years deep, the most recent figure standing at $76.4 million for Q1 2026.
- On a quarterly basis, Total Debt rose 12.65% year-over-year to $76.4 million in Q1 2026; TTM through Mar 2026 was $76.4 million, a 12.65% increase from a year earlier, with the FY2025 full-year figure at $84.5 million, up 26.05% from the prior year.
- Total Debt retreated to $76.4 million in Q1 2026 per CLLS's latest filing, from $84.5 million in the prior quarter.
- Across five years, Total Debt topped out at $84.5 million in Q4 2025 and bottomed at $24.8 million in Q1 2023.
- The 5-year median for Total Debt is $63.5 million (2024), against an average of $54.8 million.
- Across the five-year window, Total Debt retreated 19.83% in 2023 and surged 173.21% in 2024, its largest moves.
- Year by year, Total Debt stood at $25.6 million in 2022, then jumped by 112.4% to $54.4 million in 2023, then increased by 23.16% to $67.0 million in 2024, then climbed by 26.05% to $84.5 million in 2025, then slipped by 9.55% to $76.4 million in 2026.
- Per Business Quant, the three latest CLLS Total Debt figures stand at $76.4 million (Q1 2026), $84.5 million (Q4 2025), and $81.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.96 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 959.06 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Cellectis | 281.48 Mn | 95.81 Mn | - | 76.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 76.40 Mn |
| Dec 31, 2025 | 84.47 Mn |
| Sep 30, 2025 | 81.64 Mn |
| Jun 30, 2025 | 74.09 Mn |
| Mar 31, 2025 | 67.82 Mn |
| Dec 31, 2024 | 67.02 Mn |
| Sep 30, 2024 | 66.93 Mn |
| Jun 30, 2024 | 63.47 Mn |
| Mar 31, 2024 | 67.79 Mn |
| Dec 31, 2023 | 54.41 Mn |
| Sep 30, 2023 | 48.31 Mn |
| Jun 30, 2023 | 45.46 Mn |
| Mar 31, 2023 | 24.81 Mn |
| Dec 31, 2022 | 25.62 Mn |
| Sep 30, 2022 | 25.08 Mn |
| Jun 30, 2022 | 26.95 Mn |
| Mar 31, 2022 | 30.95 Mn |
| Dec 31, 2021 | 22.38 Mn |
| Sep 30, 2021 | 22.77 Mn |
| Jun 30, 2021 | 23.48 Mn |